Half of the new drugs on the market have no added therapeutic value

Researchers looked at all drugs that came onto the US and European markets between 2011 and 2020 and how they were assessed by French and German health authorities.

Le Monde | I+D | Salud |

Leer noticia completa en el medio original
Spanish